Abiopharma

🔍 Craig Kevin James (Executive)

Company: AtaiBeckley Inc. (ATAI)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 33,051 shares of Common Stock at $1.5 per share (Direct)
  Date: 2026-06-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 41,488.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 9,528 shares of Common Stock at $1.18 per share (Direct)
  Date: 2026-06-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 51,016.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 42,579 shares of Common Stock at $4.51 per share (Direct)
  Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,437.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 33,051 shares of Stock Option at $1.5 per share (Derivative)
  Date: 2026-06-25 | Code: M | Expires: 2035-03-03 | equity_swap_involved: 0 | shares_owned_after: 673,808.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 9,528 shares of Stock Option at $1.18 per share (Derivative)
  Date: 2026-06-25 | Code: M | Expires: 2033-03-14 | equity_swap_involved: 0 | shares_owned_after: 28,608.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
• F2: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $4.50 to $4.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price
• F3: The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter.
• F4: The stock option vested as to 25% of the underlying shares on March 14, 2024, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter.